This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: The Cleveland Clinic Foundation, Other. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2013
Title: The Innovative Contributions of Ronald R. Krueger
Introduction
Ronald R. Krueger is a notable inventor based in Cleveland, OH, recognized for his significant contributions to the field of ophthalmology. He has developed innovative methods for treating glaucoma, a condition that can lead to irreversible vision loss. His work focuses on protecting the optic nerve fiber layer, which is crucial for maintaining vision.
Latest Patents
Krueger holds a patent related to treating glaucoma. The patent outlines methods for protecting the optic nerve fiber layer within the optic nerve/lamina cribrosa (ONLC) complex. The invention involves administering a therapeutically effective amount of an agent that results in crosslinking collagen in the individual's peripapillary sclera. This process stiffens the sclera and protects the optic nerve fiber layer. The patent also includes methods for treating glaucomatous optic neuropathy, emphasizing the importance of collagen crosslinking in the lamina cribrosa.
Career Highlights
Throughout his career, Ronald R. Krueger has worked with esteemed institutions, including the Cleveland Clinic Foundation. His dedication to advancing medical science has led to impactful innovations in glaucoma treatment. His work has the potential to improve the quality of life for individuals suffering from this debilitating condition.
Collaborations
Krueger has collaborated with notable professionals in the field, including Stephen L. Trokel and Ivey Thornton. These collaborations have contributed to the development and refinement of his innovative methods.
Conclusion
Ronald R. Krueger's contributions to glaucoma treatment exemplify the importance of innovation in medicine. His patented methods offer hope for better management of this challenging condition. His work continues to inspire advancements in ophthalmology and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile